August 02, 2022
Cover Story
35
8
Experts divulge where the industry is outsourcing most frequently, when companies should outsource more, and when performing tasks in-house might be best.
August 02, 2022
Development
35
8
The growth in demand of viral-vector-based gene therapies drives continuous efforts to improve viral vector manufacturing.
August 02, 2022
Downstream Processing
35
8
Automation enables intensification of downstream processes.
August 02, 2022
Upstream Processing
35
8
Successful scale-up and BLA filings for products manufactured by microbial biomanufacturing require strategic planning.
August 02, 2022
Manufacturing
35
8
This article provides an overview of solutions to address key challenges facing vaccine developers or CDMOs wishing to build their own commercial-scale mRNA production facilities.
August 01, 2022
35
8
Manufacturers are taking the first steps toward process intensification.
August 01, 2022
Analytics
35
8
A strong digital backbone is foundational in driving innovation.
August 01, 2022
Outsourcing
35
8
Automation of pharmaceutical packaging saves costs and time, say contract packagers.
August 01, 2022
Regulatory Beat
35
8
FDA and the USPTO hope to promote competition by challenging strategies designed to block timely approval of generics and biosimilars.
August 01, 2022
From the Editor
35
8
Promising applications for targeted delivery may be cresting the horizon.
August 01, 2022
35
8
Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, answers some commonly asked questions about biologics license applications.
August 01, 2022
From the CEO
35
8
How can we fix the quality manufacturing issues that come with product shortages?